Susquehanna International Group’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $779K | Sell |
|
|||||
|
2025
Q2 | $1.04M | Sell |
|
|||||
|
2025
Q1 | $1.26M | Buy |
|
|||||
|
2024
Q4 | $936K | Buy |
|
|||||
|
2024
Q3 | $460K | Sell |
|
|||||
|
2024
Q2 | $1.19M | Buy |
|
|||||
|
2024
Q1 | $743K | Sell |
|
|||||
|
2023
Q4 | $749K | Buy |
|
|||||
|
2023
Q3 | $454K | Sell |
|
|||||
|
2023
Q2 | $908K | Buy |
|
|||||
|
2023
Q1 | $600K | Buy |
|
|||||
|
2022
Q4 | $272K | Sell |
|
|||||
|
2022
Q3 | $640K | Buy |
|
|||||
|
2022
Q2 | $200K | Sell |
|
|||||
|
2022
Q1 | $507K | Sell |
|
|||||
|
2021
Q4 | $1.21M | Buy |
|
|||||
|
2021
Q3 | $953K | Buy |
|
|||||
|
2021
Q2 | $722K | Sell |
|
|||||
|
2021
Q1 | $1.77M | Buy |
|